DARUNAVIR VIATRIS 400 mg, comprimé pelliculé — 60 plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium unidose(s) de 1 comprimé(s)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930084939 -
CIP7
3008493 -
CIS
69977258 -
Registration number
EU/1/16/1140
What the source publishes
- Holder
- VIATRIS (IRLANDE)
- Active ingredients
- DARUNAVIR
- Form
- comprimé pelliculé
- Package
- 60 plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium unidose(s) de 1 comprimé(s)
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- prescription initiale hospitalière annuelle ; liste I ; renouvellement non restreint
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2017-01-04
- Prescription
- Prescription or restricted
Names this record is found by
- DARUNAVIR VIATRIS 400 mg, comprimé pelliculé — 60 plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium unidose(s) de 1 comprimé(s)
- DARUNAVIR VIATRIS 400 mg, comprimé pelliculé
- DARUNAVIR
Complete source data
{
"cis": "69977258",
"cip7": "3008493",
"form": "comprimé pelliculé",
"name": "DARUNAVIR VIATRIS 400 mg, comprimé pelliculé — 60 plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium unidose(s) de 1 comprimé(s)",
"cip13": "3400930084939",
"holder": "VIATRIS (IRLANDE)",
"routes": [
"orale"
],
"holders": [
"VIATRIS (IRLANDE)"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "157.40",
"authorisedOn": "2017-01-04",
"compositions": [
{
"name": "DARUNAVIR",
"nature": "SA",
"strength": "400 mg",
"linkageNumber": "1",
"substanceCode": "28847",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "prescription initiale hospitalière annuelle ; liste I ; renouvellement non restreint",
"dispensingFee": "1.02",
"medicinePrice": "156.38",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "DARUNAVIR VIATRIS 400 mg, comprimé pelliculé",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "60 plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium unidose(s) de 1 comprimé(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"100%"
],
"marketingDeclaredOn": "2019-02-25",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"DARUNAVIR"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"prescription initiale hospitalière annuelle",
"liste I",
"renouvellement non restreint"
],
"reimbursementIndications": "Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- SIDA ( dit VIH de type 1), en association avec une faible dose de ritonavir ou pour obtenir les posologies adaptées au traitement du SIDA (du type VIH-1) chez les adultes et la population pédiatrique à partir de l'âge de 3 ans et pesant au moins 40 kg selon certaines conditions ; JOURNAL OFFICIEL ; 13/08/09",
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/16/1140",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930084939"